To investigate the possibility that cigarette smoking and other drug use are affected by menstrual phase in smokers with Late Luteal Phase Dysphoric Disorder (LLPDD), we examined daily diaries rating menstrual symptomatology, smoking, alcohol and nonprescription drug use, and caffeine intake in nine female smokers meeting criteria for LLPDD. Menstrual symptomatology peaked during the premenstru...

OBJECTIVE To investigate the frequency of premenstrual symptoms and prevalence of PMS among young Iranian women. METHOD A cross-sectional study was carried out in 2005 among female students of Zahedan University (Iran), aged 18-27 years. Overall 300 participants were asked to complete an anonymous questionnaire assessing premenstrual symptoms. The items of the questionnaire were derived from ...

Several lines of investigation suggest that obsessivecompulsive disorder (OCD) may be associated with serotonergic dysfunction. Researchers have also suggested that serotonin plays an important role in the migraine headache process. However, there are few published reports examining the relation between clinical OCD and migraine headache. Researchers have suggested that the migraine headache sy...

In this article, we review and evaluate changes in the depressive disorders section from DSM-IV to DSM-5. We describe characteristics of three new depressive disorders: disruptive mood dysregulation disorder, premenstrual dysphoric disorder, and persistent depressive disorder. We also discuss the controversial decision in DSM-5 to remove the bereavement exclusion from the criteria for major dep...

This essay traces the history of premenstrual syndrome (PMS) in French, British, and American medical literature from 1950 to 2004. Aetiological theories, treatments and diagnostic criteria have varied over time and place, reflecting local conditions and changing notions of objectivity and evidence. During the 1970s researchers in each nation utilised different research strategies to overcome v...

Premenstrual syndrome and its most severe form, premenstrual dysphoric disorder (PMDD), are two well-defined clinical entities that affect a considerable number of women. Progesterone metabolites and certain neurotransmitters, such as gamma-aminobutyric acid and serotonin, are involved in the etiology of this condition. Until recently, the only treatment for women with PMDD was psychoactive dru...